BRIEF CLINICAL RECOMMENDATIONS: Management tactics for pregnant women and women in labor and childbirth with suspected or confirmed COVID-19 infection

Беженарь, В. Ф.; Aylamazyan, Edvard Karpovich; Zazerskaya, Irina E.; Ivanov, Dmitry O.; Arakelyan, B.V.; Баутин, А. Е.; Беттихер, О. А.; Гриненко, Г В; Dolgo-Saburova, Yu.V.; Zagorodnikova, Ksenia; Zainulina, M. S.; Ильин, А. В.; Ippolitova, M.F.; Kucheryavenko, A.N.; Мазурок, В.А.; Nesterov, I. M.; Shapkaits, V.A.

doi:10.17816/jowds20201

Cited by 5 publications

(5 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To address the safety issues for the obstetrical management and delivery of pregnant women with COVID-19, the advice for those women with SARS-CoV-2 infections during pregnancy and puerperium was prepared by numerous experts from the fields of obstetrics and gynecology, pediatrics, infectious diseases, and critical care (21,(70)(71)(72)(73)(74)(75). Similar to the recommendations for the non-pregnant, early isolation, early diagnosis, and early management are still the core criteria of prevention and control transmission for pregnant women with suspected and probable SARS-CoV-2 infection.…”

Section: Future Perspective: Management Guidelines For Obstetric Patimentioning

confidence: 99%

Potential Effect of COVID-19 on Maternal and Infant Outcome: Lesson From SARS

Wang

Han

et al. 2020

Front. Pediatr.

View full text Add to dashboard Cite

The coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, is highly infectious and its ongoing outbreak has been declared a global pandemic by the WHO. Pregnant women are susceptible to respiratory pathogens and the development of severe pneumonia, suggesting the urgent need to assess the potential maternal and infant outcome of pregnancy with COVID-19. The intrauterine vertical transmission potential of SARS-CoV-2 also remains controversial. Herein, we discuss the potential effect of COVID-19 on maternal and infant outcomes based on current studies, including those published in Chinese, in a total of 80 mothers with COVID-19 and 80 infants. We also comprehensively explored the mother-to-child transmission routes of SARS-CoV-2, in particular the route of intrauterine vertical transmission. Given SARS-CoV-2 is a sister to SARS-CoV, of the SARS-related coronavirus species, we made a comprehensive comparison between them to learn from experiences with SARS. Although there is no evidence supporting the intrauterine vertical transmission of SARS-CoV-2, our comprehensive analysis suggests that the adverse maternal and infant outcomes caused by COVID-19 cannot be underestimated. Further, we speculated that the inconsistency between nucleic acids and serological characteristics IgM to SARS-CoV-2 of infants' specimens may be caused by the disruption of the amniotic barrier by the inflammatory factors induced by SARS-CoV-2 infection. Our review is beneficial to understand the effect of SARS-CoV-2 on maternal and infant outcomes.

show abstract

Section: Future Perspective: Management Guidelines For Obstetric Patimentioning

confidence: 99%

Potential Effect of COVID-19 on Maternal and Infant Outcome: Lesson From SARS

Wang

Han

et al. 2020

Front. Pediatr.

View full text Add to dashboard Cite

show abstract

“…SARS-CoV-2 enfeksiyonlarının semptomsuz kalabildikleri gibi çok hafif semptomlarla da seyredebilir. COVID-19 enfeksiyonu olan yenidoğanlarda ateş, takipne, solunum sıkıntısı, öksürük, taşikardi, kusma, ishal, batın distansiyonu ve huzursuzluk sık görülen semptomlardır (Bezhenar et al, 2020;Ovalı, 2020). Çoğu çocuğun sadece orta ila düşük dereceli ateşi vardır hatta hiç ateşi yoktur.…”

Section: Klinik Bulgularunclassified

COVID-19 ve Yenidoğan

Karabay¹

2023

Temelden Kliniğe COVID-19

View full text Add to dashboard Cite

The severe acute respiratory syndrome is caused by the new RNA virus known as coronavirus-2 (SARS-CoV-2). SARS-COV-2 can lead to clinical pictures ranging from asymptomatic infection to severe respiratory distress in children and newborns. It is known that newborns immune systems are not sufficiently developed for infectious agents. When it comes to the mother having COVID-19, those babies are in the high-risk group because of the close contact with the mother. Children of any age can get sick with COVID-19. However, most infected children do not become as severely ill as adults, and some may show no symptoms. The symptoms of COVID-19 in infants and children differ from the symptoms of COVID-19 in adults.It's also possible that children's immune systems interact with the virus differently than adult's immune systems. Babies do not overreact because they do not know the virus well enough. Adults however, become sick because their immune systems overreact to the virus, causing more damage to their bodies.

show abstract

Section: Klinik Bulgularunclassified

Temelden Kliniğe COVID-19

Karabay¹,

Dheir²,

Yaylacı³

2023

View full text Add to dashboard Cite

Bu çalışma Creative Commons Atıf-GayrıTicari 4.0 Uluslararası (CC BY-NC 4.0) lisansı altında online olarak yayındadır. https://creativecommons.org/licenses/by-nc/4.0/ Kitap atıf vermek kaydıyla ticari amaç haricinde kopyalanabilir, düzenleenbilir, dağıtılabilir ve yeniden kullanılabilir Bu kitap içerisindeki çalışmalar, yüksek akademik standartları sağlamak adına hakem değerlendirmesinden geçmiştir. İnceleme politikalarının tamamı için bakınız: https://sauyayinlari.sakarya. edu.tr/sayfa/hakem-rehberi-61. Çıkar çatışması: Yazarların beyan edecekleri herhangi bir çıkar çatışması bulunmamaktadır.

show abstract

BRIEF CLINICAL RECOMMENDATIONS: Management tactics for pregnant women and women in labor and childbirth with suspected or confirmed COVID-19 infection

Cited by 5 publications

References 2 publications

Potential Effect of COVID-19 on Maternal and Infant Outcome: Lesson From SARS

Potential Effect of COVID-19 on Maternal and Infant Outcome: Lesson From SARS

COVID-19 ve Yenidoğan

Temelden Kliniğe COVID-19

Contact Info

Product

Resources

About